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Bufalin has been shown to induce cancer cell death through apoptotic pathways. However, the molecular mechanisms are not
well understood. In this study, we used the confocal ﬂuorescence microscopy (CFM) to monitor the spatio-temporal dynamics
of reactive oxygen species (ROS) production, Bax translocation and caspase-3 activation during bufalin-induced apoptosis in
living human lung adenocarcinoma (ASTC-a-1) cells. Bufalin induced ROS production and apoptotic cell death, demonstrated by
Hoechst 33258 staining as well as ﬂow cytometry analysis. Bax redistributed from cytosol to mitochondria from 12 to 48h after
bufalin treatment in living cells expressed with green ﬂuorescent protein Bax. Treatment with the antioxidant N-acetyl-cysteine
(NAC), a ROS scavenger, inhibited ROS generation and Bax translocation and led to a signiﬁcant protection against bufalin-
induced apoptosis. Our results also revealed that bufalin induced a prominent increase of caspase-3 activation blocked potently
by NAC. Taken together, bufalin induced ROS-mediated Bax translocation, mitochondrial permeability transition and caspase-3
activation, implying that bufalin induced apoptosis via ROS-dependent mitochondrial death pathway in ASTC-a-1 cells.
1.Introduction
Apoptosis is a highly regulated and organized cell death
process controlling the development and homeostasis of
multicellular organisms that occur under a variety of phys-
iological and pathological conditions [1]. It is characterized
by a number of well-deﬁned features including cellular mor-
phological change, chromatin condensation, oligonucleoso-
mal DNA cleavage, translocation of phosphatidylserine (PS)
from the inner to the outer leaﬂet of the plasma membrane
andactivationofafamilyofcysteineproteasescalledcaspases
[2]. Caspases activation is generally considered to be a key
hallmark of apoptosis. Caspase-3, an eﬀector caspase, has
been implicated in the execution phase of apoptosis [3].
B a x ,ad e a t he ﬀector of Bcl-2 family, plays an essential
role in the mitochondrial pathway of apoptosis [4, 5]. Bax
undergoes a conformational change and translocates from
cytosol to the outer mitochondrial membrane in the early
step of the apoptotic pathway [4]. Translocation of Bax and
Bid to the mitochondria leads to the loss of mitochondrial
membrane potential (ΔΨm)[ 4, 6–8].
Reactive oxygen species (ROS) have been identiﬁed as
importantmediatorsregulatingsignaltransduction[9].ROS
can induce injury in a variety of mammalian cells [10, 11]
and play crucial roles in the signaling pathway of drug-in-
duced preconditioning [9]. ROS generation has also been
demonstrated following the administration of many mito-
chondrial-dependent apoptotic stimuli including some
chemotherapeutic agents [12]. In many apoptosis models,
investigators have reported that ROS generation occurs
downstream of the release of cytochrome c from the
mitochondria [13] .R O Sh a v eb e e nr e p o r t e dt ob ei n - v o l v e d
in various lung cancer cells apoptosis like lung cancer
A549 cells [14] and human non-small cell lung cancer cells
(NSCLC) [15]. However, the exact mechanism of ROS-
mediated apoptosis is still unclear.
Lungcanceristheleadingcauseofcancerdeaththrough-
out the world [16]. For therapeutic purposes, lung cancer
is generally divided into small-cell lung cancer (SCLC) and
non-SCLC (NSCLC) [17], with the latter constituting major
populations [18]. Various approaches for lung cancer treat-
ment including induction of diﬀerentiation and apoptosis2 Evidence-Based Complementary and Alternative Medicine
have been attempted, but conventional chemotherapy and
radiotherapy of lung cancer are still of limited eﬀectiveness,
necessitating the development of new treatment strategy
[15]. It is of paramount importance to discover novel agents
with less severe side eﬀects and drug resistance.
Bufalinhasbeenfoundtoinducecellapoptosisinvarious
types of cancer cells, but the precise molecular mechanism is
still unclear. Bufalin is the major digoxin-like immunoreac-
tive component of Chan-Su, a traditional Chinese medicine
obtained from the skin and parotid venom glands of toad
[19]. Bufalin exhibit a variety of biological activities, such as
cardiotonic, anesthetic, blood pressure stimulation, respira-
tion and antineoplastic activities. In terms of its anti-tumor
activities,bufalinhasbeen demonstratedtoinduce apoptosis
in leukemic cells, human hepatocellular carcinoma and
prostatic cancer [20–22]. Induction of apoptosis by bufalin
in human tumor cells has been reported to associate with a
change of intracellular concentration of Na+ ions by inhibit-
ing the Na+ and K+-ATPase on the cell membrane [23, 24].
The ﬂuorescence resonance energy transfer (FRET) tech-
nique has been widely used to study protein-protein inter-
actions in living cells [25, 26]. In order to monitor caspase-
3 activation in living cells, Miura et al. [25]c o n s t r u c t e d
a FRET probe, SCAT3, which consists of enhanced cyan
ﬂuorescent protein (ECFP) as a donor, a mutant of yellow
ﬂuorescent protein (Venus) as an acceptor and a linking
peptide sequence containing a caspase-3 cleavage (DEVD)
between ECFP and Venus. Activated caspase-3 cleaves the
linker, thus, eﬀectively reduces the FRET [25]. The FRET
technique based on SCAT3 has been widely used to monitor
the spatio-temporal dynamics of caspase-3 activation in
individual living cells in real time in our previous studies
[26].
The purpose of this study was to investigate the molecu-
lar mechanism of bufalin-induced apoptosis in human lung
adenocarcinoma (ASTC-a-1) cells. In addition to conven-
tionalmethods,time-lapseﬂuorescenceconfocalmicroscopy
(CFM) and emission spectral analysis based on FRET
were used to monitor the spatio-temporal dynamics of
ROS production, Bax translocation and caspase-3 activation
during bufalin-induced apoptosis in living cells.
2. Methods
Bufalin was obtained from Alexis (Lausen, Switzerland).
Working solutions were prepared by dissolving the com-
pound in 100% ethanol before experiment. The ﬁnal
concentration of ethanol was <0.1% in all experiments.
Lipofectamine 2000 and Mitotracker Red were purchased
from Invitrogen (Carlsbad, CA, USA). NAC (ROS scave-
nger), Rhodamine 123 (Rho123) and Hoechst 33258 were
obtained from Sigma (St. Louis, MO, USA). Cell Count-
ing Kit (CCK-8) was purchased from Dojindo (Kumamoto,
Japan). Annexin V (FITC) apoptosis detection kit was ob-
tained from Bender Medsystems (Vienna, Austria) and Ac-
DEVD-AFC was purchased from Alexis (Lausen, Switzer-
land). z-VAD-fmk, a broad spectrum caspase inhibitor,
was purchased from BioVision (CA, USA). 2 ,7 -Dichloro-
dihydroﬂuorescein diacetate (DCFH-DA) was purchased
from Wako Ltd (Osaka, Japan). SCAT3 plasmid was kindly
provided by Dr. Miura [25].
2.1. Cell Culture and Transfection. ASTC-a-1 cell line was
obtained from the Department of Medicine, Jinan University
(Guangzhou, China). Dulbecco’s modiﬁed Eagle’s medium
(DMEM) was purchased from Gibco (Grand Island, NY,
USA). For ﬂuorescence studies, the cells were transferred in
35-mm dish 24–48h after transfection. The cell line stably
expressing SCAT3 was obtained from our previous studies
[26]. All the cells were cultured in DMEM supplemented
with 10% fetal calf serum with 5% CO2 at 37◦Ci na
humidiﬁed incubator.
2.2. Cell Viability Assay. Cell viability after treatment with
bufalin was measured by the CCK-8 assay. ASTC-a-1 cells
were suspended at a ﬁnal concentration of 1 × 104 cells/well
a n dc u l t u r e di na9 6 - w e l lﬂ a t - b o t t o m e dm i c r o p l a t e .A f t e r
diﬀerent treatment of cells, CCK-8 (10μl) was added to
each well containing 100μl of the culture medium and
bufalin mixture, and the plate was incubated for 1h at 37◦C.
Viable cells were counted by absorbance measurements at
450nm using auto-microplate reader (inﬁnite M200, Tecan,
Austria). All experiments were performed in triplicate on
three separate occasions.
2.3. Cell Apoptosis Detection. Cell apoptosis detection was
performed by ﬂuorescence-activated cell sorting (FACS)
analysis using a ﬂow cytometer (FCM, Arla BD, USA) with
apoptotic cells being annexin V positive/PI negative. The
exposure of PS on the extracellular side of the cell membrane
was quantiﬁed by annexin V/PI staining. Treated cells in a
6-well plate with a density of 1 × 106 were collected by
centrifugation (1200rpm for 3min) and washed by PBS.
Then cells were stained with 5μl of annexin V-FITC for
30min and 10μl propidium iodide (PI, 10μg/ml) for 10min
at room temperature. After being screened with 300-mesh
sieve, cellular DNA was detected by ﬂow cytometry (FCM)
and apoptosis rate was computed.
2.4. Morphological Examination for Apoptosis. The cells were
grown on the cover slip of a 35-mm chamber. After being
treated with bufalin for 48h in the absence or presence of
NAC at 37◦C, the cells were washed with PBS three times
and incubated with 1-μM Hoechst 33258 for 20min at room
temperature in the dark. The cells were then washed three
times with PBS and visualized under a Zeiss ﬂuorescent
microscope (Axiovert 200M). The images of Hoechst 33258
were recorded using a digital camera (Nikon, Tokyo, Japan)
with 1280 × 1280 pixels resolution.
2.5. Confocal Fluorescence Live Monitoring. Fluorescence
imaging was performed on a confocal microscope (LSM510/
ConfoCor2, Zeiss, Jena, Germany). All quantitative analyses
of the ﬂuorescence images were performed with the Zeiss
Rel3.2 image processing software (Zeiss). For time-lapse
imaging of ROS, culture dishes were mounted onto the
microscope stage equipped with a temperature-controlledEvidence-Based Complementary and Alternative Medicine 3
chamber and was stained with 10-μM DCFH-DA in PBS
for 15min at 37◦C. DCFH-DA was cleaved by intracel-
lular esterases and turned to the highly ﬂuorescent 2 ,7 -
dichlorodihydroﬂuorescein (DCF) upon oxidation by ROS.
The ﬂuorescence images of green ﬂuorescent protein (GFP)
and DCF were excited by a 488-nm laser and ﬂuorescence
emission was recorded through a 500–550-nm band-pass
ﬁlter.
2.6. Mitochondrial Size Determination. The cells were culti-
vated on a coverslip of a 35-mm chamber. At indicated times
after being treated with bufalin, the cells were washed with
PBS three times and incubated with 0.1-μMM i t o - t r a c k e r
Red for 30min at room temperature in the dark. Then the
cells were washed three times with PBS and visualized. Mito-
tracker Red was excited by a 633-nm laser and the emitted
light was recorded through a 650-nm long-pass ﬁlter. For
each condition tested the size of 100–200 mitochondria in at
least 50 diﬀerent cells was measured from three independent
experiments.
2.7. Measurement of Mitochondrial Membrane Potential
(ΔΨm). Rho123 was used to evaluate the changes of ΔΨm
by FCM. The cells were grown at a density of 1 × 105 cells
in 12-well ﬂat-bottomed microtiter plates. After treatment
with bufalin for indicated times in the absence or presence
of NAC, the cells in 1-ml PBS were stained with 1¯M Rho123
for 30min in dark at room temperature. The cells were then
collected by centrifugation (1200rpm, 3min), washed with
PBS three times and resuspended in 1-ml PBS. Fluorescence
emitted from the Rho123 was detected with a ﬂow cytometer
(FACS. Arla BD, USA).
2.8. Fluorescence Spectral Analysis Inside Living Cells. ASTC-
a-1 cells stably expressing SCAT3 were cultured in the 96-
well ﬂat-bottomed microplate for 24h. The cells were then
incubated with 0.1-μM bufalin for 48h and 1-μMS T Sf o r
12h in the presence or absence of 10-μM z-VAD-fmk or 5-
mM NAC. The emission spectra of the SCAT3 were detected
by auto-microplate reader (inﬁnite M200, Tecan, Austria). In
the meantime, emission spectra of non-transfected cells were
obtained as background. The step length of the scanning
spectra is 2nm. The excitation wavelength of SCAT3 was
409–427nm and the emission ﬂuorescence channel was 454–
600-nm band-pass.
2.9. Fluorometric Assay for Caspase-3 Activity. For the
detection of caspase-3 activity, PBS-washed cell pellets
(derived from either the medium or the adherent cells) were
resuspended in extract buﬀer (25-mM HEPES (pH 7.4),
0.1% TritonX-l00, 10% glycerol, 5-mM DTT, 1-mM phenyl-
methylsulfonyl ﬂuoride, 10-mg/ml pepstatin, and 10-mg/ml
Leupeptin) and vortexed vigorously. A 20μl of the extracts
(corresponding to 10% of the sample) were incubated with
the caspase-3 ﬂuorogenic substrates Ac-DEVD-AFC at a
100μM ﬁnal concentration at room temperature. Caspase-
3 activity was measured continuously by monitoring the
releaseofﬂuorigenicAFCat37◦C.Theexcitationwavelength
of AFC was 400nm and the emission wavelength was 530nm
usingauto-microplatereader(inﬁniteM200,Tecan,Austria).
2.10. Protein Extraction and Western Blot Analysis. For
western blot analysis, the cells were treated with 1-μMS T S
for 12h, 0.1-μM bufalin for 48h and combined treatment
with 0.1-μM bufalin and 5-mM NAC for 48h. Collected
cells were washed with cold PBS and lysed in lysis buﬀer
(50-mM Tris-HCl, pH 8.0, 150-mM NaCl, 1% Triton-100,
1-mM PMSF and protease inhibitor cocktail set I). Protein
content was quantitated using the Bradford assay. Equivalent
amounts of total protein were resolved by 15% SDS-PAGE
and transferred to nitrocellulose membranes (Millipore Co.,
Billerica, MA, USA) following the conventional protocols.
Before being immunoblotted, the membranes were blocked
in 5% non-fat milk in TBST buﬀer (10-mM Tris pH 7.5,
150-mM NaCl, 0.1% Tween 20) for 1h at room temperature.
The rabbit polyclonal anti-caspase-3 (Cell signaling, Cat.
no. 9746) was used at a dilution of 1:1000 for overnight
at 4◦C and secondary anti-rabbit IgG-HRP (Rockland,
Gilbertsville, PA, USA) was used at 1:3000 for 2h. Detection
was performed using the LI-COR Odyssey Infrared Imaging
System (LI-COR, Inc., Lincoln, NE, USA)
2.11.StatisticalAnalysis. Theresultsareexpressedasmean ±
standard deviation (SD). Statistical analysis was performed
with SPSS 10.0 software for multiple comparisons. A P-value
of <.05 was considered to be statistically signiﬁcant.
3. Results
3.1. Bufalin-Induced Cell Apoptosis. The eﬀect of bufalin on
cellviabilitywasassessedusingCCK-8.Ourdatashowedthat
bufalin induced a dose-dependent cell death (Figure 1(a)).
The dose of 0.1-μM bulfalin was then adopted in the follow-
ingexperimentsforindicatedtimes.Tofurtherdeterminethe
form of bufalin-induced cell death, we used FCM to analyze
the PS alteration and membrane disruption of cells co-
stained with annexin V-FITC and PI after bufalin treatment
(Figure 1). The cells treated with STS were analyzed as
positive control (Figure 1(c)). We found out that bufalin
induced a signiﬁcant increase in FITC ﬂuorescence (Figures
1(d) and 1(e)), while the PI ﬂuorescence in the Q1 area was
almost the same as the control (Figure 1(b)), suggesting that
bufalin induced apoptotic cell death.
3.2. ROS Involvement in Bufalin-induced Cell Apoptosis.
In order to investigate ROS generation during bufalin-
induced apoptosis, the ROS-sensitive vital dye DCF was
used to detect the production of ROS in real time by
CFM. We found out that bufalin induced a marked increase
in DCF ﬂuorescence within 30 min, which was inhibited
completely by NAC (Figure 2(a)). The dynamics of the DCF
ﬂuorescence corresponding to Figure 2(b) were shown in
Figure 2(b). These data showed that bufalin induced rapid
ROS generation within 30min in the cells.4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Bufalin-induced cell apoptosis. (a) Inhibition of bufalin on the cell viability at 48h after bufalin treatment. Cell viability was
measured by the CCK-8 assay. ∗∗P <.05, compared with control. FCM analysis of apoptosis by annexin V/PI staining for control (b),
treatment with STS (C), and treatment with bufalin for 24h (d) or 48h (e).Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Dynamics of ROS production during bufalin-induced apoptosis. (a) Fluorescence images of DCF inside living cells after treatment
with bufalin in the presence or absence of NAC. Scale bar: 10μm. (b) The dynamical progress of ROS generation corresponding to (A). Data
were obtained from three independent experiments.
We next sought to determine whether ROS were involved
in bufalin-induced cell apoptosis. Compared with the con-
trol, over 50% of cells lost viability at 48h after treat-
ment with bufalin alone, whereas pretreatment with NAC
markedlyeliminatedtheinhibitionofbufalinoncellviability
(Figure 3(a)). These results showed that bufalin induced
apoptosis via ROS-dependent pathway. The results were
further conﬁrmed by cellular morphology using Hoechst
33258 staining (Figure 3(b)) .T h ec e l l st r e a t e dw i t hb u f a l i n
displayed cell shrinkage, chromatin condensation (arrows
indicate the nuclei of apoptotic cells) and margination in
the nucleus, which were markedly prevented by treatment
with NAC (Figure 3(b)). Percentage of apoptotic cells from
Hoechst33258stainingimagesat24hafterbufalintreatment
and 48h after bufalin treatment in the absence or presence
of NAC are shown in Figure 3(c). Collectively, these results
showedthatROSwereinvolvedinbufalin-inducedcellapop-
tosis. In addition, pretreatment with z-VAD-fmk showed
signiﬁcant protection to bufalin-treated cells, indicating that
caspase family were involved in bufalin-induced apoptosis
(Figure 3(a)).
3.3. ROS Involvement in Bufalin-induced Bax Translocation.
Insomemodelsofmitochondrial-dependent apoptosis, ROS
act upstream to cause the activation of Bax or Bak [27].
To explore whether ROS acted upstream of Bax activation
in bufalin-induced apoptosis, we used CFM to image the
Bax distribution in living cells expressing GFP-Bax after STS
or bufalin treatment in the presence or absence of NAC
(Figure 4(a)). STS treatment resulted in time-dependent
Bax translocation (Figures 4(a) and 4(b)), and bufalin
also induced time-dependent Bax translocation, which was
markedly inhibited by NAC (Figures 4(a) and 4(c)). The data
were collected from 400 to 500 cells per treatment in 15–20
randomly selected image frames from at least three indepen-
dent experiments. These results implied that ROS mediated
the bufalin-induced Bax translocation and apoptosis.
3.4. Bufalin-Induced ROS-Dependent Mitochondrial Dysfunc-
tion. Sincemitochondriaplayanimportantroleintheapop-
totic process, we next evaluated whether bufalin triggered
mitochondrial events of apoptosis. One of the mitochondrial
events is the ultrastructural changes. Treating the cells with
bufalin for 48h inﬂuenced the morphology of mitochondria,
which were signiﬁcantly eliminated by NAC (Figure 5(a)).
We also found out that the size of mitochondria gradually
increased from 0.65 ± 0.09 to 0.93 ± 0.23μm after bufalin
treatment compared with the control (Figure 5(b)), while
the size of mitochondria under combined treatment with
bufalin and NAC was 0.68 ± 0.08μm. Another important
mitochondrial event related to apoptosis is the permeability
change, which is associated with a drop in mitochondrial
membrane potential (ΔΨm). We used FCM to detect the loss
of ΔΨm by measuring the percentage of cells with Rho123
ﬂuorescence under various treatments (Figure 5(c)). The
percentage of cells with Rho123 ﬂuorescence after treatment
with bufalin alone for 0, 12, 24 or 48h were 7.6%, 12.1%,
14.8% or 41.8%, respectively, with the latter reducing to
21.3% in the presence of NAC (Figure 5(c)). These results
indicated that bufalin induced a time- and ROS-dependent
loss of ΔΨm.
In addition, we monitored the dynamics of cytochrome
c release events inside single living cell co-expressing Cyt-
c-GFP and DsRed-mito using time-lapse CFM (LSM510-
Meta, Zeiss, Germany). Our data showed that cytochrome c
was not released from mitochondria to cytosol under bufalin
treatment for 24h, implying that cytochrome c was not
involved in bufalin-induced apoptosis. We also detect the6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: ROS involvement in bufalin-induced apoptosis. (a) Inhibition of z-VAD-fmk or NAC on the cytotoxicity of bufalin. (b) Typical
ﬂuorescence images of cells stained with Hoechst 33258. Magniﬁcation ×400. (c) Percentage of apoptotic cells according to Hoechst 33258
staining images. Each column represents the average obtained from three independent experiments. ∗∗P <.05, compared with control. #P
<.05, compared with treatment with bufalin alone.
caspase-9 activation during bufalin-induced apoptosis inside
living cells expressing SCAT 9 plas-mid using FRET acceptor
photobleaching and emission spectral analysis as we did in
previous studies [8, 26]. Our data showed that caspase-9 was
not activated under bufalin treatment.
3.5. Bufalin-Induced ROS-mediated Caspase-3 Activation.
Caspase-3 activation was examined during bufalin-induced
apoptosis in living cells expressed stably with SCAT3 by
monitoring the ﬂuorescence emission spectra of SCAT3,
which had been used in our previous study [26]. Bimodal
emission peaks at 480 and 524nm were observed with
430-nm excitation. The strong peak at 524nm of Venus
was due to the FRET between ECFP and Venus in control
cells (Figure 6(a)). STS activated caspase-3, which cleaved
SCAT3, and then led to a signiﬁcant decrease at the peak of
524nm and a corresponding increase at the peak of 480nm,
which was markedly inhibited by z-VAD-fmk (Figure 6(a)).Evidence-Based Complementary and Alternative Medicine 7
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Figure 4: Bufalin induced ROS-dependent Bax translocation. (a) Typical ﬂuorescence images of cells expressing GFP-Bax after diﬀerent
treatments. Mitotracker was used to label mitochondria. Scale bar: 10μm. (b) Percentage of cells with Bax translocation at 0, 6 or 12h after
STS treatment. (c) Percentage of cells with Bax translocation at 0, 12, 24 or 48h after bufalin treatment in the absence or presence of NAC.
Data were collected in 400–500 cells per treatment in 15–20 randomly selected image frames and from three independent experiments (n
= 3). Results were presented as mean ± SD. ∗P > .05, compared with control. ∗∗P <.05, compared with control. #P <.05, compared with
treatment with bufalin alone.
Similarly, the peak at 524nm completely disappeared at 48h
after bufalin treatment, which was also inhibited by z-VAD-
fmk (Figure 6(b)), implying that bufalin activated caspase-
3. In order to verify whether ROS were involved in the
bufalin-induced caspase-3 activation, we also measured the
emission spectra of SCAT3 after combined treatment with
bufalin and NAC. NAC signiﬁcantly attenuated the decrcease
atthepeakof524nmcomparedwithbufalintreatmentalone
(Figure 6(c)), indicating ROS were involved in the bufalin-
induced caspase-3 activation.
Western blot analysis was performed to further con-
ﬁrm bufalin-induced ROS-dependent caspase-3 activation.
Caspase-3 was primarily present as the 35-kDa pro-form for
the untreated cells (Figure 6(d), lane 1). Following exposure
to STS for 12h, caspase-3 activation was detected by the
loss of pro-form and the appearance of processed caspase-3,8 Evidence-Based Complementary and Alternative Medicine
0h 24h 48h 48h
Control Bufalin Bufalin Bufalin+NAC
10μm1 0 μm1 0 μm1 0 μm
(a)
0
0.2
0.4
0.6
0.8
1
1.2
D
i
a
m
e
t
e
r
o
f
m
i
t
o
c
h
o
n
d
r
i
a
(
μ
m
)
Control Bufalin
24h
Bufalin
48h
∗∗
∗∗
#
Bufalin + NAC 48h
(b)
0
50
100
150
200
250
300
350
0
50
100
150
200
250
300
350
0
50
100
150
200
250
0
50
100
150
200
250
0
50
100
150
200
300
350 400
C
o
u
n
t
C
o
u
n
t
C
o
u
n
t
C
o
u
n
t
C
o
u
n
t
102 103 104 105 102 103 104 105 102 103 104 105 102 103 104 105 102 103 104 105
0h 12h 24h 48h 48h
7.6% 12.1% 14.8% 41.8% 21.3%
Control Bufalin Bufalin Bufalin Bufalin+NAC
Rhodamin 123 ﬂuorescence
P2 P2 P2 P2 P2
(c)
Figure 5: Mitochondrial dysfunction induced by bufalin. (a) Typical ﬂuorescent images of mitochondria under diﬀerent treatments. The
mitochondria in bufalin-treated cells were obviously swollen. Scale bar: 10μm. (b) Quantiﬁcation of mitochondrial width under diﬀerent
treatments. ∗∗P <.05, compared with control. #P <.05, compared with treatment with bufalin alone. (c) FCM analysis of mitochondrial
membrane potential (ΔΨm) loss induced by bufalin. The proportions of cells with reduced Rho123 ﬂuorescence were shown. Experiments
were performed in triplicate with similar results.
p17 fragment from cleavage of caspase-3 (Figure 6(d),l a n e
4). Treatment with bufalin for 48h showed the same result
(Figure 6(d) lane 2). In addition, bufalin-induced caspase-3
activation was blocked by combined treatment with bufalin
and NAC (Figure 6(d),l a n e3 ) .
We next used AFC to further detect caspase-3 activa-
tion during bufalin-induced apoptosis. AFC release is an
indicator of caspase-3 activation [28]. The level of caspase
enzymatic activity in the cell lysate is directly proportional to
theﬂuorescencesignaldetectedwithaﬂuorescentmicroplate
reader. As shown in Figure 6(e), after incubation with Ac-
DEVD-AFC for 1h, bufalin treatment induced nearly a 3-
fold increase in caspase-3 activity compared with control.
In contrast, the cleavage of Ac-DEVD-AFC in response to
caspase-3 activation was blocked by combined treatment
with bufalin and NAC (Figure 6(e)).
Taken together, these results demonstrated that bufalin
induced ROS-mediated caspase-3 activation.
4. Discussion
In this study, we for the ﬁrst time used ﬂuorescence tech-
niquesandthetime-lapseCFMtorevealthatbufalininduced
apoptosis via ROS-dependent mitochondrial pathway in
living ASTC-a-1 cells. Bufalin-induced ROS production
reached the maximum within 30min. Furthermore, ROSEvidence-Based Complementary and Alternative Medicine 9
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Figure 6: Caspase-3 activation induced by bufalin via ROS-dependent pathway. (a) STS-induced caspase-3 activation. (b) Bufalin-induced
caspase-3 activation. (c) ROS-mediated bufalin-induced caspase-3 activation. (d) Western blot assay of ROS-mediated caspase-3 activation
induced by bufalin. (e) Fluorometric assay of ROS-mediated caspase-3 activation induced by bufalin.∗∗P <.05, compared with control; #P
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Figure 7: Schematic representation of the bufalin-induced apoptotic pathway in ASTC-a-1 cells. Once engaged by bufalin, two signal
pathways are activated. One is the death receptor-mediated pathway and the other is the mitochondrion pathway. Omi/HtrA2: high
temperature requirement protein A2; Smac/Diablo: second mitochondria derived activator of caspase/direct inhibitor of an apoptosis-
binding protein; AIF: apoptosis inducing factor.
mediated Bax translocation and the loss of mitochondrial
potential. It has important clinical signiﬁcance to guide the
treatment for lung cancers.
Our results showed that bufalin-induced ROS produc-
tion was not just generated from mitochondria. Bufalin
induced ROS generation throughout the whole cells
(Figure 2(a)), which was similar to the results of ROS
involvement in lung cancer A549 cells and prostate cell lines
apoptosis [14, 22]. However, a number of other reports
showed that bufalin inhibited Na+–K+-ATPase [20, 23, 24],
which increased mitochondrial production of ROS [24].
ROS may act upstream of mitochondrial membrane
permeabilization and mediate mitochondrial dysfunction
in bufalin-induced apoptosis. ROS generation has been
reported to occur following mitochondrial outer membrane
permeabilization [27]. However, our results showed that
ROS acted upstream of the bufalin-induced mitochon-
dria dysfunctions and mitochondrial network dismantling
(Figure 5). ROS may promote MPT by causing the oxidation
ofthiolgroupsontheadeninenucleotidetranslocator,which
is believed to form part of the MPT pore [29].
One point worthy to be mentioned is that not all Bax
translocate to mitochondria in response to bufalin. Some
Bax clusters do not co-localize with mitochondria. Instead,
they were associated with one or two round mitochondrias
(Figure 5(a)). STS treatment led to the accumulation or tar-
getingofBaxtomitochondriaasshowninFigure 5(a),which
was in accordance with previous studies [30]. It indicates
that the mechanism of bufalin-induced Bax translocation is
diﬀerent from that of STS. STS induces Bax insertion into
mitochondria membranes [30]. However, bufalin induces
Baxtranslocation to thesurfaceor around the mitochondria.
To investigate which initiator caspase is involved in
this apoptosis process, we detected whether caspase-8 was
involved in bufalin-induced apoptosis inside living cells
expressing the FRET-Bid plasmid using FRET acceptor
photobleaching and emission spectral analysis as we did in
previous studies [8, 26]. Our data showed that caspase-8
was activated in bufalin-induced apoptosis. Caspase-3 plays
an important role in drug-induced cytotoxic apoptosis in
NSCLC [31]. Here, we demonstrated that caspase-3 was acti-
vated in a ROS-dependent pathway after bufalin treatment
(Figure 6). However, caspase-3 was still activated partially if
eliminating ROS (Figures 6(c) and 6(e)), implying that there
may be some alternative pathways to activate caspase-3 in
addition to a ROS-dependent caspase-3 activation pathway
in response to bufalin treatment.
According to the experimental data, we summarize the
signaling pathways (Figure 7) related to bufalin-induced
apoptosis in ASTC-a-1 cells. Once engaged by bufalin, two
signal pathways are activated. One is the extrinsic pathway,
in which bufalin induced caspase-8 activation, which subse-
quently activated caspase-8 directly activates caspase-3. The
other is the intrinsic pathway, in which bufalin induced
ROS-dependent Bax translocation, loss of mitochondrial
membrane potential and caspase-3 activation. Cytochrome
c release from the mitochondria and caspase-9 activation
were not observed after bufalin treatment, suggesting thatEvidence-Based Complementary and Alternative Medicine 11
cytochrome c and caspase-9 were not involved in bufalin-
induced apoptosis. However, NAC, a ROS scavenger, can
partiallyinhibitcaspase-3activationinducedbybufalin(Fig-
ures 3(a)–3(c) ), implying that Smac/Diablo or Omi/HtrA2
released from the mitochondria antagonize the inhibitors of
apoptosis (IAPs) and contribute to activation of caspase-3
[32]. z-VAD-fmk, a broad spectrum caspases inhibitor, did
not completely inhibit cell death and caspase-3 activation
(Figures 3(b) and 6(b)), indicating that caspase-independent
apoptotic pathways may be involved in the bufalin-induced
apoptosis, inwhichAIForendonuclease Gmayplay apartial
role. Bufalin would induce AIF or endonuclease G release
from mitochondria to cytosol and translocate to nucleus,
causing DNA fragmentation and apoptosis. These imply that
bufalin triggers the signaling to induce cell apoptosis via
both death receptor-mediated and mitochondrial pathways.
We would like to further investigate how other signaling
pathways are involved in the bufalin-induced human lung
cancer cell apoptosis. We hope our ﬁndings on anticancer
eﬀects of bufalin will help us improve medical treatment and
prevention of human lung cancer.
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